DrugPatentWatch Database Preview

CAMBIA Drug Profile

« Back to Dashboard

Which patents cover Cambia, and when can generic versions of Cambia launch?

Cambia is a drug marketed by Assertio and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-nine patent family members in twenty-one countries.

The generic ingredient in CAMBIA is diclofenac potassium. There are forty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.

Summary for CAMBIA

International Patents:	29
US Patents:	4
Applicants:	1
NDAs:	1
Suppliers / Packagers:	2
Bulk Api Vendors:	40
Clinical Trials:	3
Patent Applications:	2,175
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CAMBIA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CAMBIA
Prior Art and Litigation Support	Order Prior Art and Litigation support for CAMBIA
DailyMed Link:	CAMBIA at DailyMed

Pharmacology for CAMBIA

Drug Class	Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors
Physiological Effect	Decreased Prostaglandin Production

Synonyms for CAMBIA

15307-81-0

15307-86-5 (Parent)

2-((2,6-dichlorophenyl)amino)benzeneacetic acid, monopotassium salt

AB0013318

AC-18735

AKOS015889752

AKOS015994733

AN-8291

Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monopotassium salt

C14H10Cl2KNO2

C14H10Cl2NO2.K

Cambia (TN)

Cataflam

Cataflam (TN)

CGP 45840B

CGP-45840B

CHEBI:4508

CHEMBL1200804

D00903

Diclofenac potassium

Diclofenac potassium (USAN)

Diclofenac potassium [USAN:USP]

Diclofenac potassium [USAN]

DTXSID30165212

FT-0603076

H866

HMS3656D18

I01-3215

KS-5037

KXZOIWWTXOCYKR-UHFFFAOYSA-M

L4D5UA6CB4

LS-173441

MolPort-005-937-655

Potassium (o-(2,6-dichloroanilino)phenyl)acetate

potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate

potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate

potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate

potassium 2-[2-(2,6-dichloroanilino)phenyl]acetate

potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate

PubChem5895

s3062

SC-01315

SCHEMBL40784

SW196404-4

UNII-L4D5UA6CB4

Voltfast

Zipsor

Zipsor (TN)

US Patents and Regulatory Information for CAMBIA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Assertio	CAMBIA	diclofenac potassium	FOR SOLUTION;ORAL	022165-001	Jun 17, 2009	AB	RX	Yes	Yes			Y	Y
Assertio	CAMBIA	diclofenac potassium	FOR SOLUTION;ORAL	022165-001	Jun 17, 2009	AB	RX	Yes	Yes			Y
Assertio	CAMBIA	diclofenac potassium	FOR SOLUTION;ORAL	022165-001	Jun 17, 2009	AB	RX	Yes	Yes			Y	Y
Assertio	CAMBIA	diclofenac potassium	FOR SOLUTION;ORAL	022165-001	Jun 17, 2009	AB	RX	Yes	Yes

Expired US Patents for CAMBIA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Assertio	CAMBIA	diclofenac potassium	FOR SOLUTION;ORAL	022165-001	Jun 17, 2009
Assertio	CAMBIA	diclofenac potassium	FOR SOLUTION;ORAL	022165-001	Jun 17, 2009

Paragraph IV (Patent) Challenges for CAMBIA

Drugname	Dosage	Strength	RLD	Date
	Potassium Oral Solution (Sachet)	50 mg

International Patents for CAMBIA

Country	Patent Number	Estimated Expiration
Canada	2632375
Poland	1890680
Peru	00742007
European Patent Office	2705837
South Korea	20080024202
Argentina	057378
Norway	20080352